RESMED INC Quarterly Income Tax Expense (Benefit) in USD from Q1 2010 to Q4 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Resmed Inc quarterly/annual Income Tax Expense (Benefit) history and growth rate from Q1 2010 to Q4 2024.
  • Resmed Inc Income Tax Expense (Benefit) for the quarter ending December 31, 2024 was $73.7M, a 45.5% increase year-over-year.
  • Resmed Inc Income Tax Expense (Benefit) for the twelve months ending December 31, 2024 was $286M, a 38% increase year-over-year.
  • Resmed Inc annual Income Tax Expense (Benefit) for 2024 was $244M, a 19.5% increase from 2023.
  • Resmed Inc annual Income Tax Expense (Benefit) for 2023 was $204M, a 12.7% increase from 2022.
  • Resmed Inc annual Income Tax Expense (Benefit) for 2022 was $181M, a 55.8% decline from 2021.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2024 $286M $73.7M +$23M +45.5% Oct 1, 2024 Dec 31, 2024 10-Q 2025-01-31
Q3 2024 $263M $72.1M +$19.4M +36.7% Jul 1, 2024 Sep 30, 2024 10-Q 2024-10-25
Q2 2024 $244M $65.5M +$18.4M +38.9% Apr 1, 2024 Jun 30, 2024 10-K 2024-08-09
Q1 2024 $225M $74.9M +$18.1M +31.7% Jan 1, 2024 Mar 31, 2024 10-Q 2024-04-26
Q4 2023 $207M $50.7M +$1.88M +3.85% Oct 1, 2023 Dec 31, 2023 10-Q 2025-01-31
Q3 2023 $206M $52.8M +$1.45M +2.83% Jul 1, 2023 Sep 30, 2023 10-Q 2024-10-25
Q2 2023 $204M $47.1M +$4.11M +9.55% Apr 1, 2023 Jun 30, 2023 10-K 2024-08-09
Q1 2023 $200M $56.9M +$9.57M +20.2% Jan 1, 2023 Mar 31, 2023 10-Q 2024-04-26
Q4 2022 $190M $48.8M +$13.2M +37.3% Oct 1, 2022 Dec 31, 2022 10-Q 2024-01-25
Q3 2022 $177M $51.3M -$3.86M -7% Jul 1, 2022 Sep 30, 2022 10-Q 2023-10-27
Q2 2022 $181M $43M -$1.08M -2.45% Apr 1, 2022 Jun 30, 2022 10-K 2024-08-09
Q1 2022 $182M $47.3M -$249M -84% Jan 1, 2022 Mar 31, 2022 10-Q 2023-04-28
Q4 2021 $431M $35.5M +$4.46M +14.3% Oct 1, 2021 Dec 31, 2021 10-Q 2023-01-27
Q3 2021 $427M $55.2M +$17.7M +47.2% Jul 1, 2021 Sep 30, 2021 10-Q 2022-10-28
Q2 2021 $409M $44.1M +$9.85M +28.8% Apr 1, 2021 Jun 30, 2021 10-K 2023-08-11
Q1 2021 $399M $296M +$268M +940% Jan 1, 2021 Mar 31, 2021 10-Q 2022-04-29
Q4 2020 $131M $31.1M +$12.9M +70.8% Oct 1, 2020 Dec 31, 2020 10-Q 2022-01-28
Q3 2020 $118M $37.5M +$7.04M +23.1% Jul 1, 2020 Sep 30, 2020 10-Q 2021-10-29
Q2 2020 $111M $34.3M +$7.3M +27.1% Apr 1, 2020 Jun 30, 2020 10-K 2022-08-12
Q1 2020 $104M $28.5M -$4M -12.3% Jan 1, 2020 Mar 31, 2020 10-Q 2021-04-30
Q4 2019 $108M $18.2M -$3.44M -15.9% Oct 1, 2019 Dec 31, 2019 10-Q 2021-01-29
Q3 2019 $112M $30.4M -$2.71M -8.16% Jul 1, 2019 Sep 30, 2019 10-Q 2020-10-30
Q2 2019 $114M $27M -$4.14M -13.3% Apr 1, 2019 Jun 30, 2019 10-K 2021-08-17
Q1 2019 $118M $32.5M +$12.5M +62.4% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-01
Q4 2018 $106M $21.6M -$111M -83.6% Oct 1, 2018 Dec 31, 2018 10-Q 2020-01-31
Q3 2018 $217M $33.1M +$10.8M +48.2% Jul 1, 2018 Sep 30, 2018 10-Q 2019-10-25
Q2 2018 $206M $31.1M +$11.1M +55.5% Apr 1, 2018 Jun 30, 2018 10-K 2020-08-13
Q1 2018 $195M $20M -$149K -0.74% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-03
Q4 2017 $195M $132M +$113M +579% Oct 1, 2017 Dec 31, 2017 10-Q 2019-02-01
Q3 2017 $82M $22.4M +$5.54M +33% Jul 1, 2017 Sep 30, 2017 10-Q 2018-10-26
Q2 2017 $76.5M $20M -$14.3M -41.7% Apr 1, 2017 Jun 30, 2017 10-K 2019-08-08
Q1 2017 $90.8M $20.2M +$1.96M +10.8% Jan 1, 2017 Mar 31, 2017 10-Q 2018-04-27
Q4 2016 $88.8M $19.5M +$1.35M +7.42% Oct 1, 2016 Dec 31, 2016 10-Q 2018-01-24
Q3 2016 $87.4M $16.8M +$291K +1.76% Jul 1, 2016 Sep 30, 2016 10-Q 2017-10-27
Q2 2016 $87.2M $34.3M +$17.7M +106% Apr 1, 2016 Jun 30, 2016 10-K 2018-08-17
Q1 2016 $69.5M $18.2M -$5.17M -22.1% Jan 1, 2016 Mar 31, 2016 10-Q 2017-04-28
Q4 2015 $74.7M $18.1M -$6.21M -25.5% Oct 1, 2015 Dec 31, 2015 10-Q 2017-01-25
Q3 2015 $80.9M $16.5M -$2.14M -11.5% Jul 1, 2015 Sep 30, 2015 10-Q 2016-10-28
Q2 2015 $83M $16.7M -$2.24M -11.9% Apr 1, 2015 Jun 30, 2015 10-K 2017-08-04
Q1 2015 $85.3M $23.4M +$432K +1.88% Jan 1, 2015 Mar 31, 2015 10-Q 2016-04-29
Q4 2014 $84.8M $24.3M +$1.51M +6.59% Oct 1, 2014 Dec 31, 2014 10-Q 2016-01-28
Q3 2014 $83.3M $18.7M -$2.47M -11.7% Jul 1, 2014 Sep 30, 2014 10-Q 2015-10-27
Q2 2014 $85.8M $18.9M +$4.08M +27.6% Apr 1, 2014 Jun 30, 2014 10-K 2016-08-05
Q1 2014 $81.7M $22.9M -$136K -0.59% Jan 1, 2014 Mar 31, 2014 10-Q 2015-04-29
Q4 2013 $81.9M $22.8M +$2.37M +11.6% Oct 1, 2013 Dec 31, 2013 10-Q 2015-01-30
Q3 2013 $79.5M $21.1M +$1.5M +7.66% Jul 1, 2013 Sep 30, 2013 10-Q 2014-10-31
Q2 2013 $78M $14.8M -$6.85M -31.6% Apr 1, 2013 Jun 30, 2013 10-K 2015-08-07
Q1 2013 $84.8M $23.1M +$3.69M +19% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-01
Q4 2012 $81.2M $20.5M +$399K +1.99% Oct 1, 2012 Dec 31, 2012 10-Q 2014-01-29
Q3 2012 $80.8M $19.6M +$3.66M +22.9% Jul 1, 2012 Sep 30, 2012 10-Q 2013-10-30
Q2 2012 $77.1M $21.7M +$2.93M +15.6% Apr 1, 2012 Jun 30, 2012 10-K 2014-08-08
Q1 2012 $74.2M $19.4M +$1.72M +9.74% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-01
Q4 2011 $72.4M $20.1M -$406K -1.98% Oct 1, 2011 Dec 31, 2011 10-Q 2013-01-31
Q3 2011 $72.9M $16M -$3.87M -19.5% Jul 1, 2011 Sep 30, 2011 10-Q 2012-10-31
Q2 2011 $76.7M $18.7M Apr 1, 2011 Jun 30, 2011 10-K 2013-08-13
Q1 2011 $17.7M -$1.15M -6.12% Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-01
Q4 2010 $20.5M Oct 1, 2010 Dec 31, 2010 10-Q 2012-02-02
Q3 2010 $19.8M Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-03
Q1 2010 $18.8M Jan 1, 2010 Mar 31, 2010 10-Q 2011-05-03
* An asterisk sign (*) next to the value indicates that the value is likely invalid.